Silence Therapeutics PLC (SLN.L)

SLN.L on London Stock Exchange

222.00GBp
7:06am EDT
Price Change (% chg)

-4.00p (-1.77%)
Prev Close
226.00p
Open
222.25p
Day's High
222.25p
Day's Low
222.00p
Volume
2,759
Avg. Vol
22,683
52-wk High
388.75p
52-wk Low
185.00p

SLN.L

Chart for SLN.L

About

Silence Therapeutics plc (Silence Therapeutics) is engaged in the research and development of pharmaceutical products. Silence Therapeutics is engaged in the discovery, development and delivery of ribonucleic acid interference (RNAi) therapeutics for the treatment of diseases. The Company’s product, Atu027, is in a phase Ib/2a... (more)

Overall

Beta: 2.23
Market Cap (Mil.): £117.52
Shares Outstanding (Mil.): 52.00
Dividend: --
Yield (%): --

Financials

  SLN.L Industry Sector
P/E (TTM): -- 102.68 35.77
EPS (TTM): -0.20 -- --
ROI: -41.21 -0.70 18.27
ROE: -41.21 -1.57 19.16
Search Stocks

BRIEF-Silence Therapeutics proposes placing to raise minimum of 10 mln stg

* Proposed placing to raise a minimum of £10 million by way of accelerated book build

28 Apr 2014

BRIEF-Silence Therapeutics looking at balance sheet options

* Actively considering certain options to strengthen its balance sheet

19 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks